Navigation Links
Observant LLC Expands Senior Management Team
Date:1/3/2008

Strategic market research partner to the pharmaceutical and biotechnology

industries strengthens specialist expertise

BOSTON, Jan. 3 /PRNewswire/ -- Observant LLC has announced the appointment of two senior executives with a passion for research excellence and a commitment to client service. John Hartman, Ph.D., a social scientist and statistician, has joined the firm as Vice President. Dr. Hartman's research has focused on the mathematical analysis of cross-national healthcare data; and his programming work has emphasized how best to present the complex relationships he uncovers to his clients in intuitive visual forms that are business actionable. Advances in computational power and statistical methodology have dramatically changed the ways in which data are analyzed and displayed, but such methods cannot be applied in a rote, unthinking manner. As Dr Hartman notes, "Real gains can be made in the way we display the results of our quantitative analyses. Many of the current visual displays fail to show variations in the precision of our estimates or how a subset of respondents may possess very different attitudes from the larger sample." Dr. Hartman believes that it is important to bear in mind that it's the creative mixture of therapeutic category expertise and rigorous data analysis that yields business critical insights.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080103/NETH101-a )

(Photo: http://www.newscom.com/cgi-bin/prnh/20080103/NETH101-b )

The company is also pleased to announce that Jennifer Potter, Ph.D., M.P.H., has joined the firm as a Director. A clinical psychologist, Dr. Potter joins the firm from Harvard Medical School where her clinical research specialties included pain, substance use disorders, and the design and conduct of clinical trials. She has been a market research consultant for several years, managing studies across a range of therapeutic categories. Dr. Potter strengthens the company's scientific expertise in understanding the business implications of clinical trial design choices. As clinical trial designs become increasingly complex, how these impact physician prescribing behaviors becomes even more critical. Dr. Potter also believes strongly that knowledge of health behavior and clinical behavior should be applied to market research. According to Dr. Potter, "While gauging a doctor's or patient's enthusiasm for a product is a good first step, applying psychological principles of behavior change to market research enhances our clients' ability to influence product uptake."

Observant LLC is a strategic market research partner to the pharmaceutical and biotechnology industries worldwide. The firm offers a full spectrum of research and consulting services including analytically sophisticated quantitative studies and best-in-class qualitative research studies. Observant LLC supports its clients by conducting research in North America, Europe, Asia, South America, and Australia. Observant LLC principals and personnel have cross-industry backgrounds in consulting and public health and have published extensively on research methods and health science. For more information about the company, or to contact Dr. Hartman or Dr. Potter, please visit: http://www.observant.biz.


'/>"/>
SOURCE Observant LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
2. HealthTrust Expands Contract With Instrumentation Laboratory for Critical Care Portfolio to Include Consorta
3. CSL Behring Expands Into Middle East Market with Haemate(R) P
4. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
5. Lucid Expands Support Internationally: Dr. Colin Stahel appointed Director for Asia Pacific Region
6. Siemens Expands the SOMATOM Definition(TM) Line With Worlds First Adaptive CT Scanner
7. VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease
8. Southern Research Expands Sales and Marketing Agreement with Absorption Systems to Service European Market
9. Imaging Diagnostic Systems Expands Key Patent Coverage
10. EPI-Q, Inc. Expands Capabilities with Addition of Anthony Vita, MD, MPH and Peter Herout, PharmD
11. Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Maryland (PRWEB) , ... January 18, 2017 , ... ... two new federally funded bio-focused Manufacturing Innovation Institutes (MII). U.S. Secretary of Commerce ... in Manufacturing Biopharmaceuticals (NIIMBL), and the Department of Defense has announced the award ...
(Date:1/18/2017)... ... 2017 , ... Researchers from a new study are stating that if levels of ... cancer treatment, this indicates there is still remaining prostate cancer cells that are more likely ... test has always been an indicator of whether a man’s prostate cancer is growing ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... to sell research and genetic testing lab equipment from two different leading institutes. This ... and Northeast regions of the United States. This 1-day online auction will take ...
(Date:1/18/2017)... , ... January 18, 2017 , ... Thirty-six startup companies ... credits by the Pennsylvania Department of Community and Economic Development in 2016 as part ... located in the University City Keystone Innovation Zone and represent the highest number of ...
Breaking Biology Technology:
(Date:1/12/2017)... NEW YORK , Jan. 12, 2017  New research ... around the office of the future.  1,000 participants were simply ... last three months which we may consider standard issue.  Insights ... office of 2017 were also gathered from futurists and industry ... and Dr. James Canton .  Some ...
(Date:1/11/2017)... DES MOINES, Iowa , Jan. 11, 2017 /PRNewswire/ ... another industry first with the release of its patent-pending ... to quickly and reliably perform calibrations, securely upload data ... more flexibility for the customer. "Fighting drunk ... not only for the public at large, but also ...
(Date:1/6/2017)... 2017  Privately-held CalciMedica, Inc., announced that it ... of a novel calcium release-activated calcium (CRAC) channel ... Acute pancreatitis, sudden painful inflammation of ... can be very serious.  In severe cases it can ... hospital stays, time in the ICU and substantial ...
Breaking Biology News(10 mins):